Impaired Glucose Tolerance

As per available reports about 100 journals, 162 Conferences, 30 workshops are presently dedicated exclusively to impaired glucose tolerance and about 366282 articles are being published on the current trends in impaired glucose tolerance. In terms of research annually, USA, India, Japan, Brazil and Canada are some of the leading countries where maximum studies related to industry management are being carried out. As reported in Impaired Fasting Glucose and Impaired Glucose Tolerance Implications for care Impaired glucose tolerance is defined by an elevated 2-h plasma glucose concentration (≥140 and <200 mg/dl) after a 75-g glucose load on the oral glucose tolerance test (OGTT) in the presence of an FPG concentration <126 mg/dl. Impaired glucose tolerance (IGT) is a pre-diabetic state of hyperglycemia that is associated with insulin resistance and increased risk of cardiovascular pathology.

Journal of Diabetes & Metabolism is an academic journal – hosted by OMICS International – a pioneer in open access publishing–and is listed among the top 10 journals in impaired glucose tolerance. Each year research scientists have noticed a rise in the number of congresses being held in this field. Journal of Diabetes & Metabolism provides a unique platform to researchers and scientist to explore the advanced and latest research developments in the field of impaired glucose tolerance, thus bridging the gap between researchers and young scientists.

OMICS International – a pioneer in organizing international conferences which organizes scientific conferences on Clinical Sciences, Engineering & Applied Sciences, Life Sciences, Medical Sciences, Omics & Management and Pharmaceutical/Chemistry and it is a perfect platform for global networking. Omics group is introducing an International Conference on Targeting Diabetes with Novel Therapeutics from September 14 - 16, 2015 at Las Vegas USA. The major focus of congress will be target and therapeutics.